16 Dec 16

‘Brazil Merck to negotiate to negotiate a lower price for the drug . According to Reuters, Brazil Merck asked the cost of efavirenz by 65 cents per dose should be reduced by $ 1.57 per dose. An unnamed source said that Merck offered the drug for $ 1.10 per patient per day to sell, but Brazil rejected the offer. Merck sells efavirenz for $ 1.80 per daily dose in most middle-income countries, reports the Reuters news agency. – Temporao on Thursday said that Merck’s offer ‘inadequate’and that he expects a new proposal from Merck ‘at any moment.

More than 1,000 research abstracts will be in the SLEEP meeting, a joint venture of the AASM introduced and the Sleep Research Society. The three – and-a-half-day scientific meeting will light new findings that enhance the understanding of the processes of sleep and aid the diagnosis and treatment of sleep disorders such as insomnia, narcolepsy and sleep apnea.Banks expressed optimism that MDGs could be reached by the 2015 deadline. Made but on aid commitments, NPR Morning Edition report keep. ‘Despite the despite the skepticism, in spite of the fast-approaching deadline of 2015, the MDGs have to reach,’Ban said according German wavelength (Breitenbach / Levitz.